Increasing prevalence of hypogonadism in adult men worldwide is expected to drive
growth of the testosterone replacement therapy market.
Myasthenia gravis (MG) is a type of chronic autoimmune neuromuscular disease which
causes weakness in skeletal muscles in the arms and legs.
The global myelodysplastic syndrome treatment market was valued at US$ 2,213.2 million
in 2017 and is expected to witness a CAGR of 12.7% during the forecast period 2017–2025.
Increasing demand for compact and smart devices for estimating pressure are the major
factors boosting growth of the global pressure monitoring device market.
Increasing number of chronic kidney disease patients, rising number of kidney failure
incidences, and long waiting list for kidney transplants is expected to boost the
The global Adult Vaccines Market was valued at US$ 12,806.49 million in 2017 and is
expected to witness a robust CAGR of 7.1% over the forecast period (2017 - 2025).